← UNIVERSAL HEALTH SERVICES INC
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Net Income (Loss) Attributable to Parent | $702.4m |
$752.3m
+7.10%
|
$779.7m
+3.64%
|
$814.9m
+4.51%
|
$944.0m
+15.84%
|
$991.6m
+5.05%
|
$675.6m
-31.87%
|
$717.8m
+6.24%
|
$1.1b
+59.11%
|
$1.5b
+30.36%
|
— | |
| Net Income (Loss) Available to Common Stockholders, Basic | — | — | — | — | — | — | — | $717.5m |
$1.1b
+59.17%
|
$1.5b
+30.36%
|
— | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $747.2m | $771.3m | $797.9m | $827.5m | $952.8m | $987.6m | $657.0m | $719.3m | $1.2b | $1.5b | — | |
| Net Income (Loss) Attributable to Noncontrolling Interest | $44.8m | $19.0m | $18.2m | $12.7m | $8.8m | ($4.0m) | ($18.6m) | $1.5m | $21.0m | $22.4m | — | |
| Depreciation and amortization | $416.6m | $447.8m | $453.0m | $490.4m | $510.5m | $533.2m | $581.9m | $568.0m | $584.8m | $618.7m | $641.2m | |
| Depreciation | $350.8m | $388.4m | $410.0m | $455.6m | $478.8m | $501.6m | $544.0m | $535.6m | $559.6m | $594.0m | $641.2m | |
| Deferred Income Tax Expense (Benefit) | ($10.4m) | ($36.8m) | ($10.5m) | ($36.3m) | ($27.0m) | ($29.5m) | ($17.6m) | ($18.0m) | ($33.5m) | $50.7m | — | |
| Share-based Payment Arrangement, Noncash Expense | $48.1m | $56.7m | $66.6m | $69.4m | $65.8m | $73.7m | $85.4m | $87.7m | $99.3m | $95.7m | $95.4m | |
| Impairment of Intangible Assets (Excluding Goodwill) | — | — | — | — | — | — | — | $0 | $0 | $0 | — | |
| Impairment of Intangible Assets, Finite-lived | — | — | $49.0m | — | — | — | — | — | — | — | — | |
| Other Nonoperating Income (Expense) | — | — | $14.2m | $13.2m | $14k | $13.9m | ($10.4m) | ($28.3m) | $2.2m | $134.2m | — | |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts Receivable | $87.9m | $24.7m | $42.2m | $42.1m | $145.9m | $8.9m | $258.3m | $182.4m | ($67.4m) | $318.0m | ($363.3m) | |
| Net Cash Provided by (Used in) Operating Activities | $1.3b |
$1.2b
-8.22%
|
$1.3b
+13.39%
|
$1.4b
+7.28%
|
$2.4b
+64.08%
|
$883.7m
-62.56%
|
$996.0m
+12.71%
|
$1.3b
+27.29%
|
$2.1b
+63.05%
|
$1.9b
-9.81%
|
$1.8b
-3.44%
|
|
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Property, Plant, and Equipment | $519.9m | $557.5m | $665.0m | $634.1m | $731.3m | $855.7m | $734.0m | $743.1m | $943.8m | $1.0b | ($989.6m) | |
| Gain (Loss) on Investments | — | — | — | — | — | — | — | — | — | $93.3m | ($93.3m) | |
| Unrealized Gain (Loss) on Investments | — | — | — | — | — | — | — | — | — | $93.0m | — | |
| Payments to Acquire Businesses, Net of Cash Acquired | $613.8m | $22.9m | $110.5m | $8.0m | $52.0m | $105.4m | $20.3m | $3.7m | $19.0m | $47.8m | ($44.3m) | |
| Net Cash Provided by (Used in) Investing Activities | ($1.2b) | ($624.4m) | ($813.4m) | ($688.4m) | ($802.6m) | ($914.5m) | ($647.3m) | ($763.3m) | ($911.1m) | ($1.1b) | ($925.2m) | |
| Cash flows from financing activities: | ||||||||||||
| Repayments of Long-term Debt | $459.2m | $143.1m | $830.5m | $57.1m | $962.6m | $3.0b | $89.4m | $85.5m | $2.6b | $43.5m | ($226.7m) | |
| Payments for Repurchase of Common Stock | $353.4m | $364.4m | $397.4m | $770.5m | $206.7m | $1.2b | $832.9m | $547.4m | $670.8m | $968.0m | — | |
| Payments of Ordinary Dividends, Common Stock | $38.9m | $38.2m | $37.3m | $53.0m | $17.3m | $65.9m | $58.4m | $55.5m | $53.3m | $51.3m | ($49.6m) | |
| Proceeds from Issuance of Common Stock | $9.5m | $10.3m | $10.2m | $10.8m | $12.3m | $13.4m | $14.1m | $13.7m | $15.1m | $16.7m | $17.3m | |
| Net Cash Provided by (Used in) Financing Activities | ($125.9m) |
($519.2m)
-312.20%
|
($492.2m)
+5.19%
|
($845.0m)
-71.68%
|
($384.9m)
+54.46%
|
($1.1b)
-177.75%
|
($318.4m)
+70.21%
|
($493.9m)
-55.13%
|
($1.1b)
-131.78%
|
($749.7m)
+34.51%
|
($842.0m)
-12.31%
|
|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | — | $32.4m | ($94.0m) | $1.2b | ($1.1b) | $21.9m | $13.6m | $10.3m | $46.6m | $274.5m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | $199.7m | $105.7m | $1.3b | $178.9m | $200.8m | $214.5m | $224.8m | $271.3m | $274.5m | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $107.1m | $135.5m | $150.3m | $157.4m | $112.6m | $75.6m | $120.1m | $200.4m | $168.3m | $156.0m | — | |
| Income Taxes Paid, Net | $344.6m | $370.9m | $293.8m | $260.6m | $286.2m | $363.0m | $250.8m | $257.9m | $325.4m | $470.9m | — | |
| Additional Financial Items | ||||||||||||
| Goodwill | $3.8b | $3.8b | $3.8b | $3.9b | $3.9b | $4.0b | $3.9b | $3.9b | $3.9b | $4.0b | $0 | |
| Income Tax Expense (Benefit) | $409.2m | $363.7m | $236.6m | $238.8m | $299.3m | $305.7m | $209.3m | $221.1m | $334.8m | $461.0m | — | |
| Operating Expenses | $8.5b | $9.1b | $9.6b | $10.2b | $10.2b | $11.3b | $12.4b | $13.1b | $14.1b | $15.4b | — | |
| Operating Lease, Expense | — | — | — | — | — | $118.9m | $131.6m | $141.0m | $146.4m | $148.2m | — | |
| Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax | $107k | — | — | — | — | — | — | — | — | — | — | |
| Payments of Financing Costs | $12.4m | $76k | $13.8m | $0 | $10.3m | $18.8m | $3.2m | $308k | $12.6m | $382k | — | |
| Proceeds from Noncontrolling Interests | — | — | — | $1.4m | $18.0m | $13.2m | — | — | — | — | — | |
| Proceeds from (Payments to) Noncontrolling Interests | — | — | — | — | — | — | ($48.5m) | $2.8m | $13.0m | $22.8m | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.